Dermapharm Holding SE (DMP.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.12B |
| Enterprise Value | 2.97B |
| P/E Ratio | 15.24 |
| PEG Ratio | 0.38 |
| Price/Sales Ratio | 1.74 |
| Price/Book Ratio | 2.99 |
| Enterprise/Revenue | 2.43 |
| Enterprise/EBITDA | 8.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 1.16B |
| Revenue/Share | 21.7 |
| Gross Profit | 391.71M |
| EBITDA | 314.31M |
| Net Income | 132.41M |
| Diluted EPS | 2.46 |
Balance Sheet
| Total Cash | 254M |
| Total Cash/Share | 4.72 |
| Total Debt | 1.04B |
| Total Debt/Equity | 1.41 |
| Current Ratio | 2 |
| Book Value Per Share | 13.65 |
Price History
| 52-Week Change | 22.39 |
| 52-Week High | 51.9 |
| 52-Week Low | 31.7 |
| Moving Average 50 Days | 45.74 |
| Moving Average 200 Days | 41.25 |
Statistics
| Average Volume | 21,138 |
| Shares Outstanding | 49.54M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.88 |
| Trailing Annual Dividend Yield | 2.15 |
| Payout Ratio | 0.34 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
